ÂÜÀòÂÒÂ×

Nygel Oglesby is a Senior Research Associate at Capsida Biotherapeutics, involved in advancing therapeutic programs and supporting the company's technological evolution. Previous experience includes roles as a Senior Research Associate at Inception Therapeutics, where Nygel conducted in vivo pharmacology studies, and as a Research Associate II at Poseida Therapeutics, focusing on genetic engineering and in vivo gene editing. Nygel has managed extensive animal studies in cancer immunology at OncoSec and contributed to oncology research at Crown Bioscience. Early career experience includes roles at the U.S. Census Bureau, Randstad, Clean Harbors, Nike, and as an undergraduate research assistant at Georgia Southern University. Currently pursuing a Master of Science in Bioinformatics at the University of Birmingham, Nygel holds a Bachelor of Science in Biochemistry from Arizona State University.